Kinetics of early therapeutic response as measured by quantitative PCR predicts survival in a murine xenograft model of human T cell acute lymphoblastic leukemia. [electronic resource]
Producer: 20000810Description: 1215-24 p. digitalISSN:- 0887-6924
- Animals
- Antineoplastic Agents -- therapeutic use
- Calibration
- Cell Cycle
- Cyclophosphamide -- therapeutic use
- Cytarabine -- therapeutic use
- DNA, Neoplasm -- genetics
- Doxorubicin -- therapeutic use
- Drug Evaluation
- Etoposide -- therapeutic use
- Female
- Flow Cytometry
- Humans
- Leukemia-Lymphoma, Adult T-Cell -- drug therapy
- Methotrexate -- therapeutic use
- Mice
- Mice, SCID
- Neoplasm Transplantation
- Neoplasm, Residual
- Polymerase Chain Reaction
- Prognosis
- Reference Standards
- Risk Assessment
- Specific Pathogen-Free Organisms
- Survival Analysis
- Transplantation, Heterologous
- Tumor Cells, Cultured -- transplantation
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.